Jeanne Lenzer. Show Affiliations »
Abstract
Mesh: See more » Consumer OrganizationsDiabetes Mellitus, Type 2/drug therapyGlucagon-Like Peptide 1/adverse effectsGlucagon-Like Peptide 1/analogs & derivativesHumansHypoglycemic Agents/adverse effectsLiraglutideSafety-Based Drug WithdrawalsUnited States
Substances: See more » Hypoglycemic AgentsLiraglutideGlucagon-Like Peptide 1
Year: 2012 PMID: 22570213 DOI: 10.1136/bmj.e3259
Source DB: PubMed Journal: BMJ ISSN: 0959-8138